This is a current listing of active clinical trials at UW Cancer Center, Riverview. From this list you can select a specific cancer that you are interested in (for example, breast of colon cancer) and then review the clinical trials that are active at UW Cancer Center, Riverview for that specific disease.
Brain Cancer
no clinical trials open at this time
Breast Cancer
| CYP2D6 with Single Agent Tamoxifen for Metastatic Breast Cancer |
More Information |
| Endocrine Therapy +/- Chemotherapy for 1-3 positive nodes & RS 25 or less |
More Information |
Colon Cancer
| Irinotecan & Cetuximab +/- IMC-1121B for Advanced Colorectal Cancer |
More Information |
Lung Cancer
| Maintenance Bevacizumab, Pemetrexed or Both for Advanced Lung Cancer |
More Information |
| Prophylactic Cranial XRT vs Prophylactic Cranial XRT + Extra Cranial XRT for SCLC |
More Information |
| Sunitinib or Placebo Maintenance Therapy for Advanced Lung Cancer |
More Information |
Prostate Cancer
| Adrogen Deprivation with Radiation Therapy for Rising PSA After Prostatectomy |
More Information |
| Bicalutamide +/- MK2206 for Rising PSA for High-Risk After Primary Therapy |
More Information |
Other Types
| Bendamustine, Rituximab to Lenalidomide Maintenance for CLL/SLL |
More Information |
| Chemotherapy +/- Bevacizumab for Recurrent or Metastatic Head and Neck |
More Information |
| Early Versus Standard Zoledronic Acid with Metastatic Prostate Cancer |
More Information |
| Paclitaxel +/-IMC-A12 as Second Line for Metastatic Esophageal or GE Junction |
More Information |
| Standard Versus Longer Dosing for Zoledronic Acid in Metastatic Cancer |
More Information |
To refer a
patient to the UW Cancer Center Riverview: contact: 715/421-7442.
|
|
|
